Hepatic high-density lipoprotein receptors: roles in lipoprotein metabolism and potential for therapeutic modulation.

Abstract

High-density lipoprotein (HDL) plays an important role in protection against atherosclerosis. A major part of HDL's antiatherogenic role is through mediating reverse cholesterol transport from peripheral cells, such as macrophages and other cells in the artery wall, to the liver. Hepatic HDL receptors should, therefore, play an important role in either mediating or modulating HDL-dependent reverse cholesterol transport. The scavenger receptor class B type I (SR-BI) was first identified as a hepatic HDL receptor almost 10 years ago and is well characterized at the molecular level. This review highlights recent studies that provide insight into the cellular pathways involved in SR-BI-mediated lipid transfer between bound lipoproteins and cells, supports a role for this receptor in reverse cholesterol transport and protection against experimental atherosclerosis in mice, and explores the consequences of sequence variations in the gene encoding SR-BI in humans.

• Authors: Bernardo L Trigatti
• Journal: Current atherosclerosis reports (Curr Atheroscler Rep) Vol. 7 Issue 5 Pg. 344-50 (Sep 2005) ISSN: 1523-3804 [Print] United States
• PMID: 16105476 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Hypolipidemic Agents
• Lipoproteins, HDL
• Receptors, Lipoprotein
• high density lipoprotein receptors

Topics

• Animals
• Atherosclerosis (genetics, metabolism, prevention & control)
• Humans
• Hypolipidemic Agents (therapeutic use)
• Lipoproteins, HDL (genetics, metabolism)
• Liver (metabolism)
• Polymorphism, Genetic
• Receptors, Lipoprotein (genetics, metabolism)